IRF4 and colorectal carcinoma: For example, IRF4, hypermethylated in 99.63% of the 268 CRC samples and downregulated in all the 16 paired cancer tissues, is an important transcript factor for the regulation of interferon-inducible genes and its promoter hypermethylation is a potential biomarker for the diagnosis and therapy of CRC [19].